Drug
Tofersen
Tofersen: highest development phase Phase 3, developed by Biogen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Biogen
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tofersen NCT04856982 | Phase 3 | Amyotrophic Lateral Sclerosis Associated With a SOD1 Gene Mutation |
Latest
No recent events.
Follow Tofersen on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.